Leukemia - Table of Contents alert Volume 25 Issue 12

TABLE OF CONTENTS Volume 25, Issue 12 (December 2011) In this issue Editorial Review Original Articles Letters to the Editor Corrigendum Also new AOP Advertisement Innovative solutions for blood cell disorders Delivering the building blocks for patient care, BD Biosciences provides innovative flow cytometry reagents and instrumentation used in the identification of various markers associated with blood cell disorders. Learn more about our solutions that enable high clinical performance and reliable results for neoplastic blood cell disorder patient care. Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Take a Closer Look at Myeloproliferative Neoplasms Discover a reliable source of information and physician resources related to myeloproliferative neoplasms (MPNs). Find valuable information about the role of JAK Pathway in Myeloproliferative Neoplasms. Exploring MPN G-INC-1030929     Editorial Top Anaplastic large cell lymphoma: the current state of play from a European prospective as presented at the second annual meeting of the European Research Initiative on ALCL, 27–28 June 2011 O Merkel, L Kenner and S D Turner Leukemia 2011 25: 1795-1796; 10.1038/leu.2011.295 Full Text Review Top Modern concepts in the biology, diagnosis, differential diagnosis and treatment of primary central nervous system lymphoma M Deckert, A Engert, W Brück, A J M Ferreri, J Finke, G Illerhaus, W Klapper, A Korfel, R Küppers, M Maarouf, M Montesinos-Rongen, W Paulus, U Schlegel, H Lassmann, O D Wiestler, R Siebert and L M DeAngelis Leukemia 2011 25: 1797-1807; advance online publication, August 5, 2011; 10.1038/leu.2011.169 Abstract | Full Text Original Articles Top ACUTE LEUKEMIAS A phase Ib study of vosaroxin, an anticancer quinolone derivative, in patients with relapsed or refractory acute leukemia J E Lancet, F Ravandi, R M Ricklis, L D Cripe, H M Kantarjian, F J Giles, A F List, T Chen, R S Allen, J A Fox, G C Michelson and J E Karp Leukemia 2011 25: 1808-1814; advance online publication, July 15, 2011; 10.1038/leu.2011.157 Abstract | Full Text Interleukin-27 inhibits pediatric B-acute lymphoblastic leukemia cell spreading in a preclinical model S Canale, C Cocco, C Frasson, E Seganfreddo, E Di Carlo, E Ognio, C Sorrentino, D Ribatti, A Zorzoli, G Basso, C Dufour and I Airoldi Leukemia 2011 25: 1815-1824; advance online publication, June 24, 2011; 10.1038/leu.2011.158 Abstract | Full Text Gene expression profiling in the leukemic stem cell-enriched CD34+ fraction identifies target genes that predict prognosis in normal karyotype AML H J M de Jonge, C M Woolthuis, A Z Vos, A Mulder, E van den Berg, P M Kluin, K van der Weide, E S J M de Bont, G Huls, E Vellenga and J J Schuringa Leukemia 2011 25: 1825-1833; advance online publication, July 15, 2011; 10.1038/leu.2011.172 Abstract | Full Text CHRONIC MYELOPROLIFERATIVE NEOPLASIAS Primary myelofibrosis with or without mutant MPL: comparison of survival and clinical features involving 603 patients A Pardanani, P Guglielmelli, T L Lasho, A Pancrazzi, C M Finke, A M Vannucchi and A Tefferi Leukemia 2011 25: 1834-1839; advance online publication, June 21, 2011; 10.1038/leu.2011.161 Abstract | Full Text CYTOGENETICS AND MOLECULAR GENETICS The Interlaboratory RObustness of Next-generation sequencing (IRON) study: a deep sequencing investigation of TET2, CBL and KRAS mutations by an international consortium involving 10 laboratories A Kohlmann, H-U Klein, S Weissmann, S Bresolin, T Chaplin, H Cuppens, E Haschke-Becher, B Garicochea, V Grossmann, B Hanczaruk, K Hebestreit, C Gabriel, I Iacobucci, J H Jansen, G te Kronnie, L van de Locht, G Martinelli, K McGowan, M R Schweiger, B Timmermann, P Vandenberghe, B D Young, M Dugas and T Haferlach Leukemia 2011 25: 1840-1848; advance online publication, June 17, 2011; 10.1038/leu.2011.155 Abstract | Full Text ANIMAL MODELS Eμ/miR-125b transgenic mice develop lethal B-cell malignancies Y Enomoto, J Kitaura, K Hatakeyama, J Watanuki, T Akasaka, N Kato, M Shimanuki, K Nishimura, M Takahashi, M Taniwaki, C Haferlach, R Siebert, M J S Dyer, N Asou, H Aburatani, H Nakakuma, T Kitamura and T Sonoki Leukemia 2011 25: 1849-1856; advance online publication, July 8, 2011; 10.1038/leu.2011.166 Abstract | Full Text Differential requirements for c-Myc in chronic hematopoietic hyperplasia and acute hematopoietic malignancies in Pten-null mice J Zhang, Y Xiao, Y Guo, P Breslin, S Zhang, W Wei, Z Zhang and J Zhang Leukemia 2011 25: 1857-1868; advance online publication, September 16, 2011; 10.1038/leu.2011.220 Abstract | Full Text LYMPHOMA The different epidemiologic subtypes of Burkitt lymphoma share a homogenous micro RNA profile distinct from diffuse large B-cell lymphoma D Lenze, L Leoncini, M Hummel, S Volinia, C G Liu, T Amato, G De Falco, J Githanga, H Horn, J Nyagol, G Ott, J Palatini, M Pfreundschuh, E Rogena, A Rosenwald, R Siebert, C M Croce and H Stein Leukemia 2011 25: 1869-1876; advance online publication, June 24, 2011; 10.1038/leu.2011.156 Abstract | Full Text Lenalidomide can be safely combined with R-CHOP (R2CHOP) in the initial chemotherapy for aggressive B-cell lymphomas: phase I study G S Nowakowski, B LaPlant, T M Habermann, C E Rivera, W R Macon, D J Inwards, I N Micallef, P B Johnston, L F Porrata, S M Ansell, R R Klebig, C B Reeder and T E Witzig Leukemia 2011 25: 1877-1881; advance online publication, July 1, 2011; 10.1038/leu.2011.165 Abstract | Full Text Hypoxia-microRNA-16 downregulation induces VEGF expression in anaplastic lymphoma kinase (ALK)-positive anaplastic large-cell lymphomas E Dejean, M H Renalier, M Foisseau, X Agirre, N Joseph, G R de Paiva, T Al Saati, J Soulier, C Desjobert, L Lamant, F Prósper, D W Felsher, J Cavaillé, H Prats, G Delsol, S Giuriato and F Meggetto Leukemia 2011 25: 1882-1890; advance online publication, July 22, 2011; 10.1038/leu.2011.168 Abstract | Full Text MYELOMA The novel JAK inhibitor CYT387 suppresses multiple signalling pathways, prevents proliferation and induces apoptosis in phenotypically diverse myeloma cells K A Monaghan, T Khong, C J Burns and A Spencer Leukemia 2011 25: 1891-1899; advance online publication, July 26, 2011; 10.1038/leu.2011.175 Abstract | Full Text Letters to the Editor Top Exposure to tungsten induces DNA damage and apoptosis in developing B lymphocytes C Guilbert, A D R Kelly, L A Petruccelli, M Lemaire and K K Mann Leukemia 2011 25: 1900-1904; advance online publication, June 24, 2011; 10.1038/leu.2011.160 Full Text Impact of TP53 mutation and 17p deletion in mantle cell lymphoma A M Halldórsdóttir, A Lundin, F Murray, L Mansouri, S Knuutila, C Sundström, A Laurell, H Ehrencrona, B Sander and R Rosenquist Leukemia 2011 25: 1904-1908; advance online publication, July 1, 2011; 10.1038/leu.2011.162 Full Text Sequence analysis of 515 kinase genes in chronic lymphocytic leukemia X Zhang, M Reis, R Khoriaty, Y Li, P Ouillette, J Samayoa, H Carter, R Karchin, M Li, L A Diaz, Jr, V E Velculescu, N Papadopoulos, K W Kinzler, B Vogelstein and S N Malek Leukemia 2011 25: 1908-1910; advance online publication, June 24, 2011; 10.1038/leu.2011.163 Full Text Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-Azacytidine M T Voso, E Fabiani, A Piciocchi, C Matteucci, L Brandimarte, C Finelli, E Pogliani, E Angelucci, G Fioritoni, P Musto, M Greco, M Criscuolo, L Fianchi, M Vignetti, V Santini, S Hohaus, C Mecucci and G Leone Leukemia 2011 25: 1910-1913; advance online publication, July 15, 2011; 10.1038/leu.2011.170 Full Text GSK3 inhibitors enhance retinoic acid receptor activity and induce the differentiation of retinoic acid-sensitive myeloid leukemia cells J Si, L Mueller and S J Collins Leukemia 2011 25: 1914-1918; advance online publication, July 26, 2011; 10.1038/leu.2011.171 Full Text Wilms' tumor 1 single-nucleotide polymorphism rs16754 does not predict clinical outcome in adult acute myeloid leukemia A Renneville, N Boissel, N Helevaut, O Nibourel, C Terré, C Pautas, C Gardin, X Thomas, P Turlure, O Reman, C Berthon, H Dombret, S Castaigne and C Preudhomme Leukemia 2011 25: 1918-1921; advance online publication, July 15, 2011; 10.1038/leu.2011.173 Full Text Corrigendum Top In vivo expression of an aberrant MYB-GATA1 fusion induces leukemia in the presence of GATA1 reduced levels E Belloni, D Shing, C Tapinassi, A Viale, P Mancuso, O Malazzi, E Gerbino, V Dall'Olio, I Egurbide, M D Odero, F Bertolini and P G Pelicci Leukemia 2011 25: 1922; 10.1038/leu.2011.241 Full Text Advertisement Ensure your access If you are unable to access the articles in this Table of Contents e-alert, your library may not subscribe to this journal. Our online recommendation form is a simple way to make your librarian aware that this journal is valuable to your research. Recommend now.   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Leukemia. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2011 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.